HMP Market Access Insights

Oncology Value-Based Care: Risky Business (Part 1)

Part 1 of HMP MAI’s podcast on value-based cancer care looking at traditional provider priorities, how VBC attempts to adjust those priorities, and who some of the largest VBC players are in primary and cancer care.

Hot Topics of 2022

In this episode, we look back on the most critical topics covered by our research this year: the Inflation Reduction Act of 2022, value-based care from a payer perspective, and evolving provider revenue and survival strategies.

Enhancing Oncology Model

In this episode, we analyze the next rendition of CMMI's Oncology Care Model -  Enhancing Oncology Model - and what it means for oncology market access

Consolidation 2.0 (part 2)

Our second podcast for 2022 focuses on trends in vertical payer integration and reviews our concepts of “Consolidation 2.0” and “Consolidation 2.1” in which the healthcare conglomerates first begin to employ physicians, and then leverage technology to interact with patients virtually.  In this podcast we speak with Dr. Michael Kolodziej. Dr. Kolodziej’s experience includes New York Oncology Hematology, Aetna, Flatiron, and now ADVI Health, where he is VP and Chief Innovation Officer. Part 2 of 2.

Consolidation 2.0

Our first podcast for 2022 focuses on trends in vertical payer integration and reviews our concepts of “Consolidation 2.0” and “Consolidation 2.1” in which the healthcare conglomerates first begin to employ physicians, and then leverage technology to interact with patients virtually. In this podcast we speak with Dr. Michael Kolodziej. Dr. Kolodziej’s experience includes New York Oncology Hematology, Aetna, Flatiron, and now ADVI Health, where he is VP and Chief Innovation Officer. Part 1 of 2.

White Bagging Impacts to Drug Dispensing: Perspective from an IDN Oncology PharmD

In this episode, we explore the practice of "white bagging" - or payer directed IDN drug dispensing - and how an IDN cancer center changes internal processes to accommodate the increased operational burden. Manufacturer awareness of the practice provides insights into future opportunities for supporting their IDN clients.

IDN Oncology Pharmacy Program Considers Home Infusion

In the latest episode of our Insight to Access podcast series, we sit down with Julie Kennerly-Shah, Assistant Director of Pharmacy at the James Cancer Center, to get her perspective and personal experience on:
Key considerations in the evaluation of providing home infusion services
Benefits and challenges of shifting infusions to the home setting
Why some systems are piloting these services while others are waiting on the sidelines

Insights to Access: Electronic Health Records and Oncology Drug Management

We highlight key learning from our recent research initiative into oncology drug management and clinical support with the top EHR systems in IDN and community oncology settings.

Increasing Role of Provider Owned Specialty Pharmacy

Cindy Chen and Daniel Levis of Proximity Health's data analytics team sit down to discuss the increasing share of provider owned specialty pharmacy including barriers to entry and incentives for adoption.

Engaging with IDNs - Pt. 2

In the second of this two part series, Lee and Michael reflect on past experience working in or with Integrated Delivery Networks. Michael shares frameworks for two primary account management strategies and offers examples from past experience working with manufacturers' account teams.